AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2015
Apr 27, 2015
34975_dirs_2015-04-27_680a9ca0-7489-4049-96ad-b943fc752e6a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2015-04-23
Reporting Person: GREEN DAVID (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-23 | Common Stock | S | 118500 | $6.03 | Disposed | 529253 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 322124 | Indirect |
| Common Stock | 300000 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $5.95 to $6.16. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (d) 453,263 shares of common stock held by the Reporting Person.